|
Pricing Supplement dated March 28, 2023
(To the Prospectus dated May 23, 2022,
the Prospectus Supplement dated June 27, 2022 and
the Underlying Supplement dated June 27, 2022)
|
Filed Pursuant to Rule 424(b)(2)
Registration No. 333-265158
|
|
|
$7,166,000
Capped
Notes Due March 31, 2026
Linked to the S&P 500® Index
Global
Medium-Term Notes, Series A
|
General
| · | Unlike ordinary debt securities, the Notes do not pay interest. As described below, the Notes offer leveraged exposure to potential
appreciation of the Underlier from the Initial Underlier Value to the Final Underlier Value, subject to the Maximum Return. Investors
should be willing to forgo dividend payments and, if the Final Underlier Value is less than or equal to the Initial Underlier Value, be
willing to receive no more than their principal amount at maturity. |
| · | Unsecured and unsubordinated obligations of Barclays Bank PLC |
| · | Minimum denominations of $10,000 and integral multiples of $1,000 in excess thereof |
| · | The Notes priced on March 28, 2023 (the “Pricing Date”) and are expected to issue on or about March 31, 2023 (the “Issue
Date”). |
| Key Terms |
Terms used in this pricing supplement, but not defined herein, shall have the meanings ascribed to them in the prospectus supplement. |
| Issuer: |
Barclays Bank PLC |
| Reference Asset*: |
The S&P 500® Index (Bloomberg ticker symbol “SPX<Index>”) (the “Underlier”) |
| Payment at Maturity: |
If the Underlier Return is greater than 0.00%, you will receive
a cash payment on the Maturity Date per $1,000 principal amount Note that will provide a return equal to the Underlier Return multiplied
by the Upside Leverage Factor, subject to the Maximum Return, calculated as follows:
$1,000 + ($1,000 × the lesser of (a) Underlier
Return × Upside Leverage Factor and (b) Maximum Return)
If the Underlier Return is less than or equal to 0.00%, you
will receive a cash payment on the Maturity Date per $1,000 principal amount Note equal to $1,000.
Any payment on the Notes, including any repayment of principal,
is not guaranteed by any third party and is subject to (a) the creditworthiness of Barclays Bank PLC and (b) the risk of exercise of any
U.K. Bail-in Power (as described on page PS- 3 of this pricing supplement) by the relevant U.K. resolution authority. See “Selected
Risk Considerations” and “Consent to U.K. Bail-in Power” in this pricing supplement and “Risk Factors” in
the accompanying prospectus supplement.
|
| U.K. Bail-in Power Acknowledgment: |
Notwithstanding and to the exclusion of any other term of the Notes or any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or beneficial owner of the Notes, by acquiring the Notes, each holder and beneficial owner of the Notes acknowledges, accepts, agrees to be bound by and consents to the exercise of, any U.K. Bail-in Power by the relevant U.K. resolution authority. See “Consent to U.K. Bail-in Power” on page PS-3 of this pricing supplement. |
| Upside Leverage Factor: |
2.00 |
| Maximum Return: |
24.00%. Accordingly, if the Underlier Return is greater than or equal to 12.00%, you will receive the Maximum Return of 24.00%, which entitles you to the maximum payment at maturity of $1,240.00 per $1,000 principal amount Note. |
| Underlier Return: |
Final Underlier Value – Initial Underlier Value
Initial Underlier Value |
| Initial Underlier Value: |
3,971.27, which is the Closing Level of the Underlier on the Pricing Date. |
| Final Underlier Value: |
The arithmetic average of the Closing Levels of the Underlier on the Averaging Dates (rounded to two decimal places) |
| Closing Level*: |
Closing Level has the meaning set forth under “Reference Assets—Indices—Special Calculation Provisions” in the prospectus supplement. |
| Averaging Dates†: |
March 20, 2026, March 23, 2026, March 24, 2026, March 25, 2026 and March 26, 2026. The final Averaging Date, March 26, 2026, is the “Final Valuation Date.” |
| Maturity Date†: |
March 31, 2026 |
| Calculation Agent: |
Barclays Bank PLC |
| CUSIP/ISIN: |
06749NUV2 / US06749NUV27 |
| * | If the Underlier is discontinued or if the sponsor of the Underlier fails to publish the Underlier, the Calculation Agent may select
a successor index or, if no successor index is available, will calculate the value to be used as the Closing Level of the Underlier. In
addition, the Calculation Agent will calculate the value to be used as the Closing Level of the Underlier in the event of certain changes
in or modifications to the Underlier. For more information, see “Reference Assets—Indices—Adjustments Relating to Securities
with an Index as a Reference Asset” in the accompanying prospectus supplement. |
| † | Each Averaging Date may be postponed if that Averaging Date is not a scheduled trading day or if a market disruption event occurs
on that Averaging Date as described under “Reference Assets—Indices—Market Disruption Events for Securities with an
Index of Equity Securities as a Reference Asset” in the accompanying prospectus supplement. In addition, the Maturity Date will
be postponed if that day is not a business day or if the Final Valuation Date is postponed as described under “Terms of the Notes—Payment
Dates” in the accompanying prospectus supplement. |
| |
Initial
Issue Price1,2 |
Price
to Public |
Agent’s
Commission2 |
Proceeds
to Barclays Bank PLC |
| Per Note |
$1,000 |
100% |
2% |
98% |
| Total |
$7,166,000 |
$7,166,000 |
$143,320 |
$7,022,680 |
| 1 | Our estimated value of the Notes on the Pricing Date, based on our internal pricing models, is $982.50 per Note. The estimated
value is less than the initial issue price of the Notes. See “Additional Information Regarding Our Estimated Value of the Notes”
on page PS-12 of this pricing supplement. |
| 2 | J.P. Morgan Securities LLC and JPMorgan Chase Bank, N.A. will act as placement agents for the Notes. The placement agents will
forgo fees for sales to fiduciary accounts. The total fees represent the amount that the placement agents receive from sales to accounts
other than such fiduciary accounts. The placement agents will receive a fee from the Issuer or one of its affiliates that will not exceed
$20.00 per Note. |
Investing in the Notes involves a number of risks.
See “Risk Factors” beginning on page S-9 of the prospectus supplement and “Selected Risk Considerations” beginning
on page PS-9 of this pricing supplement.
We may use this pricing supplement in the initial sale of the Notes.
In addition, Barclays Capital Inc. or any other of our affiliates may use this pricing supplement in market resale transactions in any
Notes after their initial sale. Unless we or our agent informs you otherwise in the confirmation of sale, this pricing supplement is being
used in a market resale transaction.
The Notes will not be listed on any U.S. securities exchange or
quotation system. Neither the U.S. Securities and Exchange Commission (the “SEC”) nor any state securities commission has
approved or disapproved of these Notes or determined that this pricing supplement is truthful or complete. Any representation to the contrary
is a criminal offense.
The Notes constitute our unsecured and unsubordinated obligations.
The Notes are not deposit liabilities of Barclays Bank PLC and are not covered by the U.K. Financial Services Compensation Scheme or insured
by the U.S. Federal Deposit Insurance Corporation or any other governmental agency or deposit insurance agency of the United States, the
United Kingdom or any other jurisdiction.
 |
JPMorgan
Placement Agent |
Additional Terms Specific to the Notes
You should read this pricing supplement together with the prospectus
dated May 23, 2022, as supplemented by the prospectus supplement dated June 27, 2022 relating to our Global Medium-Term Notes, Series
A, of which these Notes are a part, and the underlying supplement dated June 27, 2022. This pricing supplement, together with the documents
listed below, contains the terms of the Notes and supersedes all prior or contemporaneous oral statements as well as any other written
materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures,
brochures or other educational materials of ours. You should carefully consider, among other things, the matters set forth under “Risk
Factors” in the prospectus supplement, as the Notes involve risks not associated with conventional debt securities. We urge you
to consult your investment, legal, tax, accounting and other advisors before you invest in the Notes.
You may access these documents on the SEC website at www.sec.gov as
follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website):
| · | Prospectus dated May 23, 2022: |
http://www.sec.gov/Archives/edgar/data/312070/000119312522157585/d337542df3asr.htm
| · | Prospectus supplement dated June 27, 2022: |
http://www.sec.gov/Archives/edgar/data/0000312070/000095010322011301/dp169388_424b2-prosupp.htm
| · | Underlying supplement dated June 27, 2022: |
http://www.sec.gov/Archives/edgar/data/0000312070/000095010322011304/dp169384_424b2-underl.htm
Our SEC file number is 1-10257. As used in this pricing supplement,
“we,” “us” and “our” refer to Barclays Bank PLC.
Consent to U.K. Bail-in Power
Notwithstanding and to the exclusion of any other term of the Notes
or any other agreements, arrangements or understandings between us and any holder or beneficial owner of the Notes, by acquiring the Notes,
each holder and beneficial owner of the Notes acknowledges, accepts, agrees to be bound by and consents to the exercise of, any U.K. Bail-in
Power by the relevant U.K. resolution authority.
Under the U.K. Banking Act 2009, as amended, the relevant U.K. resolution
authority may exercise a U.K. Bail-in Power in circumstances in which the relevant U.K. resolution authority is satisfied that the resolution
conditions are met. These conditions include that a U.K. bank or investment firm is failing or is likely to fail to satisfy the Financial
Services and Markets Act 2000 (the “FSMA”) threshold conditions for authorization to carry on certain regulated activities
(within the meaning of section 55B FSMA) or, in the case of a U.K. banking group company that is a European Economic Area (“EEA”)
or third country institution or investment firm, that the relevant EEA or third country relevant authority is satisfied that the resolution
conditions are met in respect of that entity.
The U.K. Bail-in Power includes any write-down, conversion, transfer,
modification and/or suspension power, which allows for (i) the reduction or cancellation of all, or a portion, of the principal amount
of, interest on, or any other amounts payable on, the Notes; (ii) the conversion of all, or a portion, of the principal amount of, interest
on, or any other amounts payable on, the Notes into shares or other securities or other obligations of Barclays Bank PLC or another person
(and the issue to, or conferral on, the holder or beneficial owner of the Notes such shares, securities or obligations); (iii) the cancellation
of the Notes and/or (iv) the amendment or alteration of the maturity of the Notes, or amendment of the amount of interest or any other
amounts due on the Notes, or the dates on which interest or any other amounts become payable, including by suspending payment for a temporary
period; which U.K. Bail-in Power may be exercised by means of a variation of the terms of the Notes solely to give effect to the exercise
by the relevant U.K. resolution authority of such U.K. Bail-in Power. Each holder and beneficial owner of the Notes further acknowledges
and agrees that the rights of the holders or beneficial owners of the Notes are subject to, and will be varied, if necessary, solely to
give effect to, the exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority. For the avoidance of doubt, this consent
and acknowledgment is not a waiver of any rights holders or beneficial owners of the Notes may have at law if and to the extent that any
U.K. Bail-in Power is exercised by the relevant U.K. resolution authority in breach of laws applicable in England.
For more information, please see “Selected Risk Considerations—Risks
Relating to the Issuer—You May Lose Some or All of Your Investment If Any U.K. Bail-in Power Is Exercised by the Relevant U.K. Resolution
Authority” in this pricing supplement as well as “U.K. Bail-in Power,” “Risk Factors—Risks Relating to the
Securities Generally—Regulatory action in the event a bank or investment firm in the Group is failing or likely to fail, including
the exercise by the relevant U.K. resolution authority of a variety of statutory resolution powers, could materially adversely affect
the value of any securities” and “Risk Factors—Risks Relating to the Securities Generally—Under the terms of the
securities, you have agreed to be bound by the exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority” in
the accompanying prospectus supplement.
What Is the Total Return on the Notes at Maturity, Assuming a
Range of Performances for the Underlier?
The following table and examples illustrate the hypothetical payment
at maturity and the hypothetical total return on the Notes. The “total return” as used in this pricing supplement is the number,
expressed as a percentage, that results from comparing the payment at maturity per $1,000 principal amount Note to $1,000. The table and
examples set forth below assume a hypothetical Initial Underlier Value of 100.00 and the Final Underlier Values set forth below. The actual
Initial Underlier Value is set forth under “Key Terms” above, and the actual Final Underlier Value will be the arithmetic
average of the Closing Levels of the Underlier on the Averaging Dates. The hypothetical Initial Underlier Value of 100.00 has been chosen
for illustrative purposes only and does not represent the actual Initial Underlier Value. For historical Closing Levels of the Underlier,
see the historical information set forth under the section titled “The S&P 500® Index” below. Each hypothetical
payment at maturity or total return set forth below is for illustrative purposes only and may not be the actual payment at maturity or
total return applicable to a purchaser of the Notes. The numbers appearing in the following table and examples have been rounded for ease
of analysis. The table and examples below do not take into account any tax consequences from investing in the Notes.
| Final Underlier Value |
Underlier Return |
Payment at Maturity |
Total Return on Notes |
| 200.00 |
100.00% |
$1,240.00 |
24.00% |
| 190.00 |
90.00% |
$1,240.00 |
24.00% |
| 180.00 |
80.00% |
$1,240.00 |
24.00% |
| 170.00 |
70.00% |
$1,240.00 |
24.00% |
| 160.00 |
60.00% |
$1,240.00 |
24.00% |
| 150.00 |
50.00% |
$1,240.00 |
24.00% |
| 140.00 |
40.00% |
$1,240.00 |
24.00% |
| 130.00 |
30.00% |
$1,240.00 |
24.00% |
| 120.00 |
20.00% |
$1,240.00 |
24.00% |
| 115.00 |
15.00% |
$1,240.00 |
24.00% |
| 112.00 |
12.00% |
$1,240.00 |
24.00% |
| 110.00 |
10.00% |
$1,200.00 |
20.00% |
| 105.00 |
5.00% |
$1,100.00 |
10.00% |
| 102.50 |
2.50% |
$1,050.00 |
5.00% |
| 100.00 |
0.00% |
$1,000.00 |
0.00% |
| 95.00 |
-5.00% |
$1,000.00 |
0.00% |
| 90.00 |
-10.00% |
$1,000.00 |
0.00% |
| 85.00 |
-15.00% |
$1,000.00 |
0.00% |
| 80.00 |
-20.00% |
$1,000.00 |
0.00% |
| 70.00 |
-30.00% |
$1,000.00 |
0.00% |
| 60.00 |
-40.00% |
$1,000.00 |
0.00% |
| 50.00 |
-50.00% |
$1,000.00 |
0.00% |
| 40.00 |
-60.00% |
$1,000.00 |
0.00% |
| 30.00 |
-70.00% |
$1,000.00 |
0.00% |
| 20.00 |
-80.00% |
$1,000.00 |
0.00% |
| 10.00 |
-90.00% |
$1,000.00 |
0.00% |
| 0.00 |
-100.00% |
$1,000.00 |
0.00% |
Hypothetical Examples of Amount Payable at Maturity
The following examples illustrate how the payment at maturity and total
return in different hypothetical scenarios are calculated.
Example 1: The value of the Underlier increases from the Initial
Underlier Value of 100.00 to a Final Underlier Value of 120.00, resulting in an Underlier Return of 20.00%.
Because the Underlier Return of 20.00% is positive and the Underlier
Return multiplied by the Upside Leverage Factor of 2.00 exceeds the Maximum Return of 24.00%, the investor receives a payment at
maturity of $1,240.00 per $1,000 principal amount Note, which is the maximum payment on the Notes.
The total return on the Notes is 24.00%, which is the Maximum Return.
Example 2: The value of the Underlier increases from the Initial
Underlier Value of 100.00 to a Final Underlier Value of 105.00, resulting in an Underlier Return of 5.00%.
Because the Underlier Return of 5.00% is positive and the Underlier
Return multiplied by the Upside Leverage Factor of 2.00 is less than the Maximum Return of 24.00%, the investor receives a payment
at maturity of $1,100.00 per $1,000 principal amount Note, calculated as follows:
$1,000 + ($1,000 × Underlier Return ×
Upside Leverage Factor)
$1,000 + ($1,000 × 5.00% × 2.00) =
$1,100.00
The total return on the Notes is 10.00%.
Example 3: The value of the Underlier decreases from the Initial
Underlier Value of 100.00 to a Final Underlier Value of 50.00, resulting in an Underlier Return of -50.00%.
Because the Underlier Return of -50.00% is negative, the investor receives
a payment at maturity of $1,000.00 per $1,000 principal amount Note.
The total return on the Notes is 0.00%.
Selected Purchase Considerations
The Notes are not suitable for
all investors. The Notes may be a suitable investment for you if all of the following statements are true:
| · | You do not seek an investment that produces periodic interest or coupon payments or other sources of current income. |
| · | You anticipate that the Underlier Return will be positive, and you are willing and able to accept the risk that, if the Underlier
Return is negative, you will receive only the principal amount of your Notes. |
| · | You understand and accept that any potential return on the Notes is limited by the Maximum Return. |
| · | You are willing and able to accept the risks associated with an investment linked to the performance of the Underlier, as explained
in more detail in the “Selected Risk Considerations” section of this pricing supplement. |
| · | You understand and accept that you will not be entitled to receive dividends or distributions that may be paid to holders of the securities
composing the Underlier, nor will you have any voting rights with respect to the securities composing the Underlier. |
| · | You do not seek an investment for which there will be an active secondary market and you are willing and able to hold the Notes to
maturity. |
| · | You are willing and able to assume our credit risk for all payments on the Notes. |
| · | You are willing and able to consent to the exercise of any U.K. Bail-in Power by any relevant U.K. resolution authority. |
The Notes may not
be a suitable investment for you if any of the following statements are true:
| · | You seek an investment that produces periodic interest or coupon payments or other sources of current income. |
| · | You anticipate that the Underlier Return will be negative, or you are unwilling or unable to accept the risk that, if it is, you will
receive only the principal amount of your Notes. |
| · | You seek an investment with uncapped exposure to any positive performance of the Underlier. |
| · | You are unwilling or unable to accept the risks associated with an investment linked to the performance of the Underlier, as explained
in more detail in the “Selected Risk Considerations” section of this pricing supplement. |
| · | You seek an investment that entitles you to dividends or distributions on, or voting rights related to, the securities composing the
Underlier. |
| · | You seek an investment for which there will be an active secondary market and/or you are unwilling or unable to hold the Notes to
maturity. |
| · | You are unwilling or unable to assume our credit risk for all payments on the Notes. |
| · | You are unwilling or unable to consent to the exercise of any U.K. Bail-in Power by any relevant U.K. resolution authority. |
You must rely on your own
evaluation of the merits of an investment in the Notes. You should reach a decision whether to invest in the Notes after carefully
considering, with your advisors, the suitability of the Notes in light of your investment objectives and the specific information set
forth in this pricing supplement, the prospectus, the prospectus supplement and the underlying supplement.
Neither the Issuer nor Barclays Capital Inc. makes any recommendation as to the suitability of the Notes for investment.
Tax Consequences
There is uncertainty regarding the U.S. federal income tax consequences
of an investment in the Notes due to the lack of governing authority. You should review carefully the sections in the accompanying prospectus
supplement entitled “Material U.S. Federal Income Tax Consequences—Tax Consequences to U.S. Holders—Notes Treated as
Indebtedness for U.S. Federal Income Tax Purposes” and, if you are a non-U.S. holder, “—Tax Consequences to Non-U.S.
Holders.” The discussion below applies to you only if you are an initial purchaser of the Notes; if you are a secondary purchaser
of the Notes, the tax consequences to you may be different. In the opinion of our special tax counsel, Davis Polk & Wardwell LLP,
the Notes should be treated as debt instruments for U.S. federal income tax purposes. The remainder of this discussion assumes that this
treatment is correct. The following discussion supersedes the discussion in the accompanying prospectus supplement to the extent it is
inconsistent therewith.
Based on current market conditions, we intend to treat the Notes as
“contingent payment debt instruments” for U.S. federal income tax purposes, as described under “—Contingent Payment
Debt Instruments” in the accompanying prospectus supplement. The remainder of this discussion assumes that this treatment is correct.
Assuming that our treatment of the Notes as contingent payment debt
instruments is correct, regardless of your method of accounting for U.S. federal income tax purposes, you generally will be required to
accrue taxable interest income in each year on a constant yield to maturity basis at the “comparable yield,” as determined
by us, even though we will not be required to make any payment with respect to the Notes prior to maturity. Upon a sale or exchange (including
redemption at maturity), you generally will recognize taxable income or loss equal to the difference between the amount received from
the sale or exchange and your adjusted tax basis in the Notes. You generally must treat any income as interest income and any loss as
ordinary loss to the extent of previous interest inclusions, and the balance as capital loss. The deductibility of capital losses is subject
to limitations. Special rules may apply if the amount payable at maturity is treated as becoming fixed prior to maturity. You should consult
your tax adviser concerning the application of these rules.
Our treatment of the Notes will be binding on you, unless you properly
disclose to the Internal Revenue Service (the “IRS”) an alternative treatment. Also, the IRS may challenge the treatment of
the Notes as CPDIs. If the IRS successfully challenges the treatment of the Notes as CPDIs, then the Notes could be treated as original
issue discount debt instruments (that are not CPDIs) with an amount of original issue discount equal to the maximum return at maturity.
Under this treatment, if you are a U.S. holder, your annual taxable income from (and adjusted tax basis in) the Notes might be greater
than if it were based on the comparable yield, and any loss recognized upon a disposition of the Notes (including upon maturity) would
be capital loss, the deductibility of which is subject to limitations. Accordingly, this alternative treatment could result in adverse
tax consequences to you.
The discussions herein and in the accompanying prospectus supplement
do not address the consequences to taxpayers subject to special tax accounting rules under Section 451(b).
You should consult your tax advisor regarding the U.S. federal tax
consequences of an investment in the Notes, as well as tax consequences arising under the laws of any state, local or non-U.S. taxing
jurisdiction.
Non-U.S. holders. We do not believe that non-U.S. holders should
be required to provide a Form W-8 in order to avoid 30% U.S. withholding tax with respect to the excess (if any) of the Payment at Maturity
over the face amount of the Notes, although the IRS could challenge this position. However, non-U.S. holders should in any event expect
to be required to provide appropriate Forms W-8 or other documentation in order to establish an exemption from backup withholding, as
described under the heading “—Information Reporting and Backup Withholding” in the accompanying prospectus supplement.
If any withholding is required, we will not be required to pay any additional amounts with respect to amounts withheld.
Treasury regulations under Section 871(m) generally impose a withholding
tax on certain “dividend equivalents” under certain “equity linked instruments.” A recent IRS notice excludes
from the scope of Section 871(m) instruments issued prior to January 1, 2025 that do not have a “delta of one” with respect
to underlying securities that could pay U.S.-source dividends for U.S. federal income tax purposes (each an “Underlying Security”).
Based on our determination that the Notes do not have a “delta of one” within the meaning of the regulations, our special
tax counsel is of the opinion that these regulations should not apply to the Notes with regard to non-U.S. holders. Our determination
is not binding on the IRS, and the IRS may disagree with this determination. Section 871(m) is complex and its application may depend
on your particular circumstances, including whether you enter into other transactions with respect to an Underlying Security. You should
consult your tax advisor regarding the potential application of Section 871(m) to the Notes.
The discussions in the preceding paragraphs, when read in
combination with the sections entitled “Material U.S. Federal Income Tax Consequences—Tax Consequences to U.S.
Holders—Notes Treated as Indebtedness for U.S. Federal Income Tax Purposes” and, if you are a non-U.S. holder,
“—Tax Consequences to Non-U.S. Holders,” in the accompanying prospectus supplement, constitute the full opinion of
Davis Polk & Wardwell LLP regarding the material U.S. federal income tax consequences of owning and disposing of the Notes.
Comparable Yield and Projected Payment Schedule
We have determined that the “comparable yield” for the
Notes is a rate of 4.80% per annum (compounded semi-annually). Based on the comparable yield set forth above, the “projected payment
schedule” for a Note (assuming an issue price of $1,000) consists of a single projected amount equal to $1,152.92 due at maturity.
The following table states the amount of taxable interest income (without
taking into account any adjustment to reflect the difference, if any, between the actual and the projected amount of the contingent payment
on a Note) that will be deemed to have accrued with respect to a Note for each accrual period based upon the comparable yield and projected
payment schedule set forth above.
| Accrual Period |
Interest Deemed to Accrue During Accrual Period (per $1,000 principal amount Note) |
Total Interest Deemed to Have Accrued from Original Issue Date (per $1,000 principal amount Note) |
| March 31, 2023 through December 31, 2023 |
$36.29 |
$36.29 |
| January 1, 2024 through December 31, 2024 |
$50.34 |
$86.63 |
| January 1, 2025 through December 31, 2025 |
$52.78 |
$139.41 |
| January 1, 2026 through March 31, 2026 |
$13.51 |
$152.92 |
Neither the comparable yield nor the projected payment schedule
constitutes a representation by us regarding the actual cash settlement amount that we will pay on the Notes.
Selected Risk Considerations
An investment in the Notes involves significant risks. Investing in
the Notes is not equivalent to investing directly in the Underlier or any of the securities composing the Underlier. Some of the risks
that apply to an investment in the Notes are summarized below, but we urge you to read the more detailed explanation of risks relating
to the Notes generally in the “Risk Factors” section of the prospectus supplement. You should not purchase the Notes unless
you understand and can bear the risks of investing in the Notes:
Risks Relating to the Notes Generally
| · | You May Receive No More Than the Principal Amount of Your Notes — If the Underlier Return is less than or equal to 0.00%,
you will receive only the principal amount of your Notes. Therefore, you may not receive a return on the Notes. Even if the Underlier
Return is greater than 0.00%, the return on the Notes may be less than the amount that would be paid on a conventional debt security of
the Issuer of comparable maturity if the Underlier does not appreciate sufficiently over the term of the Notes. |
| · | Your Maximum Gain on the Notes Is Limited to the Maximum Return — Any positive return on your Notes will not exceed a
predetermined percentage of the principal amount, regardless of the appreciation in the value of the Underlier, which may be significant.
We refer to this percentage as the Maximum Return, which is equal to 24.00%. |
| · | No Interest Payments — As a holder of the Notes, you will not receive interest payments. |
| · | Any Payment on the Notes Will Be Determined Based on the Closing Level of the Underlier on the Dates Specified — Any
payment on the Notes will be determined based on the Closing Level of the Underlier on the dates specified. You will not benefit from
any more favorable value of the Underlier determined at any other time. |
| · | Repayment of Principal Applies Only at Maturity — You should be willing to hold your Notes to maturity. Although the
Notes provide for the repayment of your principal at maturity, if you sell your Notes prior to maturity in the secondary market, if any,
you may have to sell your Notes at a loss relative to your initial investment even if at that time the value of the Underlier has increased
from the Initial Underlier Value. See “Risks Relating to the Estimated Value of the Notes and the Secondary Market—Many Economic
and Market Factors Will Impact the Value of the Notes” below. |
| · | Owning the Notes Is Not the Same as Owning the Securities Composing the Underlier — The return on your Notes may not
reflect the return you would realize if you actually owned the securities composing the Underlier. For instance, as a holder of the Notes,
you will not have voting rights, rights to receive cash dividends or any other distributions or other rights that holders of the securities
composing the Underlier would have. |
Risks Relating to the Issuer
| · | Credit of Issuer — The Notes are unsecured and unsubordinated debt obligations of the Issuer, Barclays Bank PLC, and
are not, either directly or indirectly, an obligation of any third party. Any payment to be made on the Notes, including any repayment
of principal, is subject to the ability of Barclays Bank PLC to satisfy its obligations as they come due and is not guaranteed by any
third party. As a result, the actual and perceived creditworthiness of Barclays Bank PLC may affect the market value of the Notes and,
in the event Barclays Bank PLC were to default on its obligations, you might not receive any amount owed to you under the terms of the
Notes. |
| · | You May Lose Some or All of Your Investment If Any U.K. Bail-in Power Is Exercised by the
Relevant U.K. Resolution Authority — Notwithstanding and to the exclusion of any other term of the Notes or any other agreements,
arrangements or understandings between Barclays Bank PLC and any holder or beneficial owner of the Notes, by acquiring the Notes, each
holder and beneficial owner of the Notes acknowledges, accepts, agrees to be bound by, and consents to the exercise of, any U.K. Bail-in
Power by the relevant U.K. resolution authority as set forth under “Consent to U.K. Bail-in Power” in this pricing supplement.
Accordingly, any U.K. Bail-in Power may be exercised in such a manner as to result in you and other holders and beneficial owners of the
Notes losing all or a part of the value of your investment in the Notes or receiving a different security from the Notes, which may be
worth significantly less than the Notes and which may have significantly fewer protections than those typically afforded to debt securities.
Moreover, the relevant U.K. resolution authority may exercise the U.K. Bail-in Power without providing any advance notice to, or requiring
the consent of, the holders and beneficial owners of the Notes. The exercise of any U.K. Bail-in Power by the relevant U.K. resolution
authority with respect to the Notes will not be a default or an Event of Default (as each term is defined in the senior debt securities
indenture) and the trustee will not be liable for any action that the trustee takes, or abstains from taking, in either case, in accordance
with the exercise of the U.K. Bail-in Power by the relevant U.K. resolution authority with respect to the Notes. See “Consent to
U.K. Bail-in Power” in this pricing supplement as well as “U.K. Bail-in Power,” “Risk Factors—Risks Relating
to the Securities Generally—Regulatory action in the event a bank or investment firm in the Group is failing or likely to fail,
including the exercise by the relevant U.K. resolution authority of a variety of statutory resolution powers, could materially adversely
affect the value of any securities” and “Risk Factors—Risks Relating to the Securities Generally—Under the terms
of the securities, you have agreed to be bound by the exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority”
in the accompanying prospectus supplement. |
Risks Relating to the Underlier
| · | The Underlier Reflects the Price Return of the Securities Composing the Underlier, Not the Total Return — The return
on the Notes is based on the performance of the Underlier, which reflects changes in the market prices of the securities composing the
Underlier. The Underlier is not a “total return” index that, in addition to reflecting those price returns, would also reflect
dividends paid on the securities composing the Underlier. Accordingly, the return on the Notes will not include such a total return feature. |
| · | Adjustments to the Underlier Could Adversely Affect the Value of the Notes — The sponsor of the Underlier may add, delete,
substitute or adjust the securities composing the Underlier or make other methodological changes to the Underlier that could affect its
performance. The Calculation Agent will calculate the value to be used as the Closing Level of the Underlier in the event of certain material
changes in or modifications to the Underlier. In addition, the sponsor of the Underlier may also discontinue or suspend calculation or
publication of the Underlier at any time. Under these circumstances, the Calculation Agent may select a successor index that the Calculation
Agent determines to be comparable to the Underlier or, if no successor index is available, the Calculation Agent will determine the value
to be used as the Closing Level of the Underlier. Any of these actions could adversely affect the value of the Underlier and, consequently,
the value of the Notes. See “Reference Assets—Indices—Adjustments Relating to Securities with an Index as a Reference
Asset” in the accompanying prospectus supplement. |
Risks
Relating to Conflicts of Interest
| · | We and Our Affiliates
May Engage in Various Activities or Make Determinations That Could Materially Affect Your
Notes in Various Ways and Create Conflicts of Interest — We and our affiliates
play a variety of roles in connection with the issuance of the Notes, as described below.
In performing these roles, our and our affiliates’ economic interests are potentially
adverse to your interests as an investor in the Notes. |
In connection with
our normal business activities and in connection with hedging our obligations under the Notes, we and our affiliates make markets in and
trade various financial instruments or products for our accounts and for the account of our clients and otherwise provide investment banking
and other financial services with respect to these financial instruments and products. These financial instruments and products may include
securities, derivative instruments or assets that may relate to the Underlier or its components. In any such market making, trading and
hedging activity, investment banking and other financial services, we or our affiliates may take positions or take actions that are inconsistent
with, or adverse to, the investment objectives of the holders of the Notes. We and our affiliates have no obligation to take the needs
of any buyer, seller or holder of the Notes into account in conducting these activities. Such market making, trading and hedging activity,
investment banking and other financial services may negatively impact the value of the Notes.
In addition, the role
played by Barclays Capital Inc., as the agent for the Notes, could present significant conflicts of interest with the role of Barclays
Bank PLC, as issuer of the Notes. For example, Barclays Capital Inc. or its representatives may derive compensation or financial benefit
from the distribution of the Notes and such compensation or financial benefit may serve as an incentive to sell the Notes instead of other
investments. Furthermore, we and our affiliates establish the offering price of the Notes for initial sale to the public, and the offering
price is not based upon any independent verification or valuation.
In addition to the
activities described above, we will also act as the Calculation Agent for the Notes. As Calculation Agent, we will determine any values
of the Underlier and make any other determinations necessary to calculate any payments on the Notes. In making these determinations, we
may be required to make discretionary judgments, including determining whether a market disruption event has occurred on any date that
the value of the Underlier is to be determined; if the Underlier is discontinued or if the sponsor of the Underlier fails to publish the
Underlier, selecting a successor index or, if no successor index is available, determining any value necessary to calculate any payments
on the Notes; and calculating the value of the Underlier on any date of determination in the event of certain changes in or modifications
to the Underlier. In making these discretionary judgments, our economic interests are potentially adverse to your interests as an investor
in the Notes, and any of these determinations may adversely affect any payments on the Notes.
Risks Relating to the Estimated
Value of the Notes and the Secondary Market
| · | Lack of Liquidity — The Notes will not be listed on any securities exchange. Barclays Capital Inc. and other affiliates
of Barclays Bank PLC intend to make a secondary market for the Notes but are not required to do so, and may discontinue any such secondary
market making at any time, without notice. Barclays Capital Inc. may at any time hold unsold inventory, which may inhibit the development
of a secondary market for the Notes. Even if there is a secondary market, it may not provide enough liquidity to allow you to trade or
sell the Notes easily. Because other dealers are not likely to make a secondary market for the Notes, the price at which you may be able
to trade your Notes is likely to depend on the price, if any, at which Barclays Capital Inc. and other affiliates of Barclays Bank PLC
are willing to buy the Notes. The Notes are not designed to be short-term trading instruments. Accordingly, you should be able and willing
to hold your Notes to maturity. |
| · | Many Economic and Market Factors Will Impact the Value of the Notes — In addition to the value of the Underlier on any
day, the value of the Notes will be affected by a number of economic and market factors that may either offset or magnify each other,
including: |
| o | the expected volatility of the Underlier; |
| o | the time to maturity of the Notes; |
| o | the dividend rates on the securities composing the Underlier; |
| o | interest and yield rates in the market generally; |
| o | supply and demand for the Notes; |
| o | a variety of economic, financial, political, regulatory and judicial events; and |
| o | our creditworthiness, including actual or anticipated downgrades in our credit ratings. |
| · | The Estimated Value of Your Notes Is Lower Than the Initial Issue Price of Your Notes — The estimated value of your Notes
on the Pricing Date is lower than the initial issue price of your Notes. The difference between the initial issue price of your Notes
and the estimated value of the Notes is a result of certain factors, such as any sales commissions to be paid to Barclays Capital Inc.
or another affiliate of ours, any selling concessions, discounts, commissions or fees to be allowed or paid to non-affiliated intermediaries,
the estimated profit that we or any of our affiliates expect to earn in connection with structuring the Notes, the estimated cost that
we may incur in hedging our obligations under the Notes, and estimated development and other costs that we may incur in connection with
the Notes. |
| · | The Estimated Value of Your Notes Might Be Lower if Such Estimated Value Were Based on the Levels at Which Our Debt Securities
Trade in the Secondary Market — The estimated value of your Notes on the Pricing Date is based on a number of variables, including
our internal funding rates. Our internal funding rates may vary from the levels at which our benchmark debt securities trade in the secondary
market. As a result of this difference, the estimated value referenced above might be lower if such estimated value were based on the
levels at which our benchmark debt securities trade in the secondary market. |
| · | The Estimated Value of the Notes Is Based on Our Internal Pricing Models, Which May Prove to Be Inaccurate and May Be Different
from the Pricing Models of Other Financial Institutions — The estimated value of your Notes on the Pricing Date is based on
our internal pricing models, which take into account a number of variables and are based on a number of subjective assumptions, which
may or may not materialize. These variables and assumptions are not evaluated or verified on an independent basis. Further, our pricing
models may be different from other financial institutions’ pricing models and the methodologies used by us to estimate the value
of the Notes may not be consistent with those of other financial institutions that may be purchasers or sellers of Notes in the secondary
market. As a result, the secondary market price of your Notes may be materially different from the estimated value of the Notes determined
by reference to our internal pricing models. |
| · | The Estimated Value of Your Notes Is Not a Prediction of the Prices at Which You May Sell Your Notes in the Secondary Market, if
Any, and Such Secondary Market Prices, if Any, Will Likely Be Lower Than the Initial Issue Price of Your Notes and May Be Lower Than the
Estimated Value of Your Notes — The estimated value of the Notes will not be a prediction of the prices at which Barclays Capital
Inc., other affiliates of ours or third parties may be willing to purchase the Notes from you in secondary market transactions (if they
are willing to purchase, which they are not obligated to do). The price at which you may be able to sell your Notes in the secondary market
at any time will be influenced by many factors that cannot be predicted, such as market conditions, and any bid and ask spread for similar
sized trades, and may be substantially less than our estimated value of the Notes. Further, as secondary market prices of your Notes take
into account the levels at which our debt securities trade in the secondary market, and do not take into account our various costs related
to the Notes such as fees, commissions, discounts, and the costs of hedging our obligations under the Notes, secondary market prices of
your Notes will likely be lower than the initial issue price of your Notes. As a result, the price at which Barclays Capital Inc., other
affiliates of ours or third parties may be willing to purchase the Notes from you in secondary market transactions, if any, will likely
be lower than the price you paid for your Notes, and any sale prior to the Maturity Date could result in a substantial loss to you. |
| · | The Temporary Price at Which We May Initially Buy the Notes in the Secondary Market and the Value We May Initially Use for Customer
Account Statements, if We Provide Any Customer Account Statements at All, May Not Be Indicative of Future Prices of Your Notes —
Assuming that all relevant factors remain constant after the Pricing Date, the price at which Barclays Capital Inc. may initially buy
or sell the Notes in the secondary market (if Barclays Capital Inc. makes a market in the Notes, which it is not obligated to do) and
the value that we may initially use for customer account statements, if we provide any customer account statements at all, may exceed
our estimated value of the Notes on the Pricing Date, as well as the secondary market value of the Notes, for a temporary period after
the initial Issue Date of the Notes. The price at which Barclays Capital Inc. may initially buy or sell the Notes in the secondary market
and the value that we may initially use for customer account statements may not be indicative of future prices of your Notes. |
The S&P 500® Index
The Underlier consists of stocks of 500 companies selected to provide
a performance benchmark for the U.S. equity markets. For more information about the Underlier, see “Indices—The S&P U.S.
Indices” in the accompanying underlying supplement.
Historical Information
The graph below sets forth the historical performance of the Underlier
from January 2, 2018 to March 28, 2023, based on the daily Closing Levels of the Underlier. The Closing Level of the Underlier on March
28, 2023 was 3,971.27.
We obtained the Closing Levels of the Underlier from Bloomberg Professional®
service, without independent verification. Historical performance of the Underlier should not be taken as an indication of future performance.
Future performance of the Underlier may differ significantly from historical performance, and no assurance can be given as to the Closing
Level of the Underlier during the term of the Notes, including on any of the Averaging Dates. We cannot give you assurance that the performance
of the Underlier will result in a payment at maturity in excess of the principal amount.
PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE
RESULTS.
Certain Employee Retirement Income Security Act Considerations
Your purchase of a Note in an Individual
Retirement Account (an “IRA”) will be deemed to be a representation and warranty by you, as a fiduciary of the IRA and also
on behalf of the IRA, that (i) neither the Issuer, the placement agent nor any of their respective affiliates has or exercises any discretionary
authority or control or acts in a fiduciary capacity with respect to the IRA assets used to purchase the Note or renders investment advice
(within the meaning of Section 3(21)(A)(ii) of the Employee Retirement Income Security Act (“ERISA”)) with respect to any
such IRA assets and (ii) in connection with the purchase of the Note, the IRA will pay no more than “adequate consideration”
(within the meaning of Section 408(b)(17) of ERISA) and in connection with any redemption of the Note pursuant to its terms will receive
at least adequate consideration, and, in making the foregoing representations and warranties, you have (x) applied sound business principles
in determining whether fair market value will be paid, and (y) made such determination acting in good faith.
Additional Information Regarding Our Estimated Value of the Notes
Our internal pricing models take into account a number of variables
and are based on a number of subjective assumptions, which may or may not materialize, typically including volatility, interest rates
and our internal funding rates. Our internal funding rates (which are our internally published borrowing rates based on variables, such
as market benchmarks, our appetite for borrowing and our existing obligations coming to maturity) may vary from the levels at which our
benchmark debt securities trade in the secondary market. Our estimated value on the Pricing Date is based on our internal funding rates.
Our estimated value of the Notes might be lower if such valuation were based on the levels at which our benchmark debt securities trade
in the secondary market.
Our estimated value of the Notes on the Pricing Date is less than the
initial issue price of the Notes. The difference between the initial issue price of the Notes and our estimated value of the Notes results
from several factors, including any sales commissions to be paid to Barclays Capital Inc. or another affiliate of ours, any selling concessions,
discounts, commissions or fees to be allowed or paid to non-affiliated intermediaries, the estimated profit that we or any of our affiliates
expect to earn in connection with structuring the Notes, the estimated cost that we may incur in hedging our obligations under the Notes,
and estimated development and other costs that we may incur in connection with the Notes.
Our estimated value on the Pricing Date is not a prediction of the
price at which the Notes may trade in the secondary market, nor will it be the price at which Barclays Capital Inc. may buy or sell the
Notes in the secondary market. Subject to normal market and funding conditions, Barclays Capital Inc. or another affiliate of ours intends
to offer to purchase the Notes in the secondary market but it is not obligated to do so.
Assuming that all relevant factors remain constant after the Pricing
Date, the price at which Barclays Capital Inc. may initially buy or sell the Notes in the secondary market, if any, and the value that
we may initially use for customer account statements, if we provide any customer account statements at all, may exceed our estimated value
on the Pricing Date for a temporary period expected to be approximately six months after the initial Issue Date of the Notes because,
in our discretion, we may elect to effectively reimburse to investors a portion of the estimated cost of hedging our obligations under
the Notes and other costs in connection with the Notes that we will no longer expect to incur over the term of the Notes. We made such
discretionary election and determined this temporary reimbursement period on the basis of a number of factors, which may include the tenor
of the Notes and/or any agreement we may have with the distributors of the Notes. The amount of our estimated costs that we effectively
reimburse to investors in this way may not be allocated ratably throughout the reimbursement period, and we may discontinue such reimbursement
at any time or revise the duration of the reimbursement period after the initial Issue Date of the Notes based on changes in market conditions
and other factors that cannot be predicted.
We urge you to read the “Selected Risk Considerations”
beginning on page PS-9 of this pricing supplement.
Supplemental Plan of Distribution
J.P. Morgan Securities LLC and JPMorgan
Chase Bank, N.A. will act as placement agents for the Notes pursuant to separate placement agency agreements with the Issuer. The placement
agents will forgo fees for sales to fiduciary accounts. The placement agents will receive a fee from the Issuer or one of its affiliates
per Note as specified on the cover of this pricing supplement.
Validity of the Notes
In the opinion of Davis Polk & Wardwell LLP, as special United
States products counsel to Barclays Bank PLC, when the Notes offered by this pricing supplement have been executed and issued by Barclays
Bank PLC and authenticated by the trustee pursuant to the indenture, and delivered against payment as contemplated herein, such Notes
will be valid and binding obligations of Barclays Bank PLC, enforceable in accordance with their terms, subject to applicable bankruptcy,
insolvency and similar laws affecting creditors’ rights generally, concepts of reasonableness and equitable principles of general
applicability (including, without limitation, concepts of good faith, fair dealing and the lack of bad faith) and possible judicial or
regulatory actions or application giving effect to governmental actions or foreign laws affecting creditors’ rights, provided that
such counsel expresses no opinion as to the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law
on the conclusions expressed above. This opinion is given as of the date hereof and is limited to the laws of the State of New York. Insofar
as this opinion involves matters governed by English law, Davis Polk & Wardwell LLP has relied, with Barclays Bank PLC’s permission,
on the opinion of Davis Polk & Wardwell London LLP, dated as of May 23, 2022, filed as an exhibit to the Registration Statement on
Form F-3ASR by Barclays Bank PLC on May 23, 2022, and this opinion is subject to the same assumptions, qualifications and limitations
as set forth in such opinion of Davis Polk & Wardwell London LLP. In addition, this opinion is subject to customary assumptions about
the trustee’s authorization, execution and delivery of the indenture and its authentication of the Notes and the validity, binding
nature and enforceability of the indenture with respect to the trustee, all as stated in the opinion of Davis Polk & Wardwell LLP,
dated May 23, 2022, which has been filed as an exhibit to the Registration Statement referred to above.
iPath Series B S&P 500 V... (AMEX:VXX)
過去 株価チャート
から 3 2024 まで 4 2024
iPath Series B S&P 500 V... (AMEX:VXX)
過去 株価チャート
から 4 2023 まで 4 2024
